Skip to content

Medical Grand Rounds: Impact of COVID-19 among Older Persons

In This Article

  • On May 28, 2020, the Department of Medicine at Massachusetts General Hospital held its 12th Virtual Grand Rounds presentation related to COVID-19
  • The presentation featured a panel of experts from the Boston medical community including Christine Seel Ritchie, MD, MSPH, Sharon Levine, MD, and Jehan Alladina, MD, of Massachusetts General Hospital

On May 28, 2020, the Department of Medicine at Massachusetts General Hospital held its 12th Virtual Grand Rounds presentation related to COVID-19. The presentation focused on the impact of COVID-19 on older populations.

The panel included Mass General physicians Christine Seel Ritchie, MD, MSPH, director of research in the Division of Palliative Care and Geriatric Medicine and director of the Mongan Institute Center for Aging and Serious Illness, Sharon Levine, MD, geriatric medicine specialist, and Jehan Alladina, MD, physician in the Division of Pulmonary and Critical Care. The session was moderated by Katrina Armstong, MD, physician-in-chief in the Department of Medicine at Mass General. Other speakers included Susan L. Mitchell, MD, MPH, and Sharon K. Inouye, MD, MPH, of Beth Israel Deaconess Medical Center, and Shalender Basin, MB, BS, Laura Nelson Frain, MD, MPH, and Shoshana Streiter, MD, of Brigham and Women’s Hospital.

Watch the video »

View all COVID-19 updates

Visit the Division of Palliative Care and Geriatric Medicine at Mass General

Related topics

Related

On April 2, 2020, the Department of Medicine held its fourth virtual Grand Rounds presentation related to COVID-19. Vicki Jackson, MD, at Massachusetts General Hospital, along with other members of the Greater Boston medical community, presented on the growing role of palliative care in the response to the pandemic.

Related

In cognitively intact older adults, impaired metamemory—the ability to monitor one's memory accurately and engage in compensatory strategies when necessary—was linked to greater deposition of tau in brain regions that are vulnerable to pathologic changes in early Alzheimer's disease.